Baseline characteristics in hospital level and 3-month composite persistence of the study population
| Variables | Composite persistence* | ||||
| Overall | Level I | Level II | Level III | P value | |
| n=18 344 | n=4397 | n=5464 | n=8483 | ||
| Hospital level | |||||
| Hospital grade, n (%) | 0.72 | ||||
| Tertiary | 12 472 (68.0) | 2968 (67.5) | 3719 (68.1) | 5785 (68.2) | |
| Secondary | 5872 (32.0) | 1429 (32.5) | 1745 (31.9) | 2698 (31.8) | |
| Region, n (%) | <0.001 | ||||
| Eastern | 10 947 (59.7) | 2678 (60.9) | 3360 (61.5) | 4909 (57.9) | |
| Central | 4250 (23.2) | 1020 (23.2) | 1161 (21.3) | 2069 (24.4) | |
| Western | 3147 (17.2) | 699 (15.9) | 943 (17.3) | 1505 (17.7) | |
| Teaching hospital, n (%) | 10 276 (56.0) | 2502 (56.9) | 3046 (55.8) | 4728 (55.7) | 0.40 |
| Stroke unit, n (%) | 10 312 (56.2) | 2297 (52.2) | 3073 (56.2) | 4942 (58.3) | <0.001 |
| Hospital beds >1000, n (%) | 8725 (47.6) | 2047 (46.6) | 2731 (50.0) | 3947 (46.5) | <0.001 |
| No of neurological ward beds >80, n (%) | 9830 (53.6) | 2116 (48.1) | 2892 (52.9) | 4822 (56.8) | <0.001 |
*Composite persistence was defined as the percentage (0% to 100%) of discharge medication classes that patients were still taking at 3 months. Level I: persistence=0%; level II: 0%<persistence<100%; level III: persistence=100%.